Metraipolis › archive › dc_bdf73244a07d

Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a… — Europe PMC PMID:42176176

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42176176
DOI
10.1007/s12282-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-01T08:28:30.987Z
SHA-256 of the archived text
919b548ee00113732b672248affbe43260109943245b889305c63220ae3b1d21
Stable URL of this page
https://metraipolis.com/documento/dc_bdf73244a07d

How to cite

Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a… — Europe PMC PMID:42176176 — Europe PMC (en), https://europepmc.org/article/MED/42176176 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bdf73244a07d (Metraipolis archive dc_bdf73244a07d, sha256 919b548ee00113732b672248affbe43260109943245b889305c63220ae3b1d21)
BibTeX
@misc{dcbdf73244a07d,
  title = {Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a… — Europe PMC PMID:42176176},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42176176},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bdf73244a07d; sha256 919b548ee00113732b672248affbe43260109943245b889305c63220ae3b1d21},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42176176. Agents can read the archived copy with the MCP tool read_document.